Effects of BTK inhibitor on gefitinib-resistance non-small cell lung cancer

被引：0
|
作者：
Hong, T-M. [1 ]
Fang, Y-T. [1 ]
Chen, Y-L. [1 ]
机构：
[1] Natl Cheng Kung Univ, Tainan, Taiwan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
32P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
    Yeung, Yiu To
    Yin, Shuying
    Lu, Bingbing
    Fan, Suyu
    Yang, Ran
    Bai, Ruihua
    Zhang, Chengjuan
    Bode, Ann M.
    Liu, Kangdong
    Dong, Zigang
    EBIOMEDICINE, 2018, 28 : 51 - 61
  • [22] Src mediates ERK reactivation in gefitinib resistance in non-small cell lung cancer
    Ochi, Nobuaki
    Takigawa, Nagio
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    EXPERIMENTAL CELL RESEARCH, 2014, 322 (01) : 168 - 177
  • [23] Overexpression of Cathepsin L is associated with gefitinib resistance in non-small cell lung cancer
    F. Cui
    W. Wang
    D. Wu
    X. He
    J. Wu
    M. Wang
    Clinical and Translational Oncology, 2016, 18 : 722 - 727
  • [24] β-Catenin overexpression is associated with gefitinib resistance in non-small cell lung cancer cells
    Fang, Xia
    Gu, Pan
    Zhou, Caicun
    Liang, Aibin
    Ren, Shenxiang
    Liu, Fang
    Zeng, Yu
    Wu, Yunjin
    Zhao, Yinmin
    Huang, Binbin
    Zhang, Zongmei
    Yi, Xianghua
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 28 (01) : 41 - 48
  • [25] Gefitinib/osimertinibAcquired resistance in advanced non-small cell lung cancer: case report
    Reactions Weekly, 2021, 1863 (1) : 165 - 165
  • [26] Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib
    Costa, Daniel B.
    Nguyen, Kim-Son H.
    Cho, Young C.
    Sequist, Lecia V.
    Jackman, David M.
    Riely, GregoryJ.
    Yeap, Beow Y.
    Halmos, Balazs
    Kim, Joo H.
    Jaenne, Pasi A.
    Huberman, Mark S.
    Pao, William
    Tenen, Daniel G.
    Kobayashi, Susumu
    CLINICAL CANCER RESEARCH, 2008, 14 (21) : 7060 - 7067
  • [27] Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
    Araki, Takuya
    Yashima, Hideaki
    Shimizu, Kimihiro
    Aomori, Tohru
    Hashita, Tadahiro
    Kaira, Kyoichi
    Nakamura, Tomonori
    Yamamoto, Koujirou
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [28] Gefitinib (Iressa) trials in non-small cell lung cancer
    Johnson, DH
    LUNG CANCER, 2003, 41 : S23 - S28
  • [29] Gefitinib: an "orphan" drug for non-small cell lung cancer
    Ziogas, Dimitrios C.
    Liontos, Michalis
    Kyriazoglou, Anastasios
    Tsironis, Georgios
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (11): : 899 - 906
  • [30] Gefitinib (Iressa) for advanced non-small cell lung cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1138): : 77 - 78
12345